The New York Genome Center is the latest healthcare organization to take advantage of the cognitive learning capabilities of the IBM Watson supercomputer.

During the past year, Memorial Sloan-Kettering Cancer Center has been feeding medical literature on cancer over three decades to Watson, teaching the computer how cancer has been traditionally treated without the benefits of whole genome sequencing. With the benefit of that knowledge, New York Genome Center and IBM are developing a new Watson prototype that will use its data analytics, natural language processing and retrieval technologies to deliver more personalized treatment plans to cancer patients based on their individual genetic makeup.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access